Experts from government, the pharmaceutical and biotech industries, and medical device companies will discuss best practices to ensure compliance with clinical trial disclosure laws and regulations, the Clinical Trials.gov registry, and results database during the Drug Information Association's (DIA's) Current Advancements in Clinical Trial Disclosure: The Changing Tide (October 15-16; Chicago, IL).

Horsham, PA (PRWEB) September 17, 2008 -- Experts from government, the pharmaceutical and biotech industries, and medical device companies will discuss best practices to ensure compliance with clinical trial disclosure laws and regulations, the Clinical Trials.gov registry, and results database during the Drug Information Association's (DIA's) Current Advancements in Clinical Trial Disclosure: The Changing Tide (http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17203&eventType=Meeting) (October 15-16; Chicago, IL).

This follow-up to the successful 2007 Clinical Trial Disclosure Workshop will feature myriad topics, including:

* Challenges with journal requirements and legislation

* Academic and independent investigator compliance

* EMEA systems, requirements and developments

* Registries and results database requirements in the international community

* Company processes to handle disclosure activities

* Legislative actions and reactions

About the Drug Information Association (DIA) (http://www.diahome.org/DIAHome/)

DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact: Joe Krasowski

215-293-5812

Joe.Krasowski @ diahome.org

###

Simillar Articles

Adverse Drug Events Conference to Review Global Regulatory Requirements

Professionals who are involved in all aspects of pharmaceutical safety should attend the Drug Information Association's Adverse Drug Events in Premarketing Clinical Trials and Postmarketing...

SEC Associates Trains FDA on Key Risks and Vulnerabilities within Computer Systems Used for Human...

SEC Associates, Inc. (www.secassociates.com) recently delivered a 3-day training workshop to the U.S. Food and Drug Administration at the FDA Staff College in Rockville, Maryland.

The Center for Professional Innovation & Education (CfPIE) Announces New Biotech, Medical...

The Center for Professional Innovation & Education (CfPIE), the global leader in accredited Biotech, Medical Device, Skin/Cosmetic and Pharmaceutical Training, announced today that it will begin...

Professional Comparator Drug Sourcing and Procurement Services for Clinical Trials Growing in...

Specialized clinical trial services have exploded in popularity in the past few years. One specialized service in particular has developed into a very important component of the clinical trial...

DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory...

The Drug Information Association (DIA) will host Safety is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies (December 10-12; Marina Square, Singapore).

Home